Repligen (RGEN) Shares Outstanding (2010 - 2026)
Repligen's (RGEN) quarterly Shares Outstanding (Entity) came in at $56.4 million in Q2 2026, little changed year-over-year from $56.3 million in Q2 2025, and little changed quarter-over-quarter from $56.4 million in Q1 2026.
Analysis
Repligen (RGEN) Shares Outstanding (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Shares Outstanding (Entity) for 17 consecutive years, with $56.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.31% year-over-year to $56.4 million in Q2 2026; TTM through Jun 2026 was $56.4 million, a 0.31% change from a year earlier, with the FY2025 full-year figure at $56.3 million, changed 0.42% from the prior year.
- Shares Outstanding (Entity) was $56.4 million for Q2 2026 at Repligen, roughly flat from $56.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $56.4 million in Q2 2026 and troughed at $55.4 million in Q1 2022.
- A 5-year average of $55.9 million and a median of $55.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) grew 0.97% in 2022 and climbed 0.28% in 2024, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $55.6 million in 2022, then gained by 0.38% to $55.8 million in 2023, then rose by 0.58% to $56.1 million in 2024, then gained by 0.42% to $56.3 million in 2025, then increased by 0.18% to $56.4 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $56.4 million (Q2 2026), $56.4 million (Q1 2026), and $56.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 371.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 705.30 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 282.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 151.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 111.58 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 155.96 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 26.75 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 56.42 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 129.98 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 152.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.42 Mn |
| Mar 31, 2026 | 56.35 Mn |
| Dec 31, 2025 | 56.23 Mn |
| Sep 30, 2025 | 56.27 Mn |
| Jun 30, 2025 | 56.23 Mn |
| Mar 31, 2025 | 56.12 Mn |
| Dec 31, 2024 | 55.94 Mn |
| Sep 30, 2024 | 55.90 Mn |
| Jun 30, 2024 | 55.88 Mn |
| Mar 31, 2024 | 55.79 Mn |
| Dec 31, 2023 | 55.72 Mn |
| Sep 30, 2023 | 55.77 Mn |
| Jun 30, 2023 | 55.71 Mn |
| Mar 31, 2023 | 55.59 Mn |
| Dec 31, 2022 | 55.46 Mn |
| Sep 30, 2022 | 55.50 Mn |
| Jun 30, 2022 | 55.44 Mn |
| Mar 31, 2022 | 55.35 Mn |
| Dec 31, 2021 | 55.02 Mn |
| Sep 30, 2021 | 55.02 Mn |